Advanta VXT and Flixene PMCF Registry | MicrobiomeTrials← Back to trialsNCT07161583
Advanta VXT and Flixene PMCF Registry
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-09-25Est. Completion: 2027-12
Enrollment target: 1,000 participants Locations- Massachusetts General Hospital, Boston, Massachusetts, United States
- CHU de Brest, Brest, Brittany Region, France
Other microbiome trials you might be interested in
Post-operative Atrial FibrillationCardiovascular DiseasesPost-pericardiotomy Syndrome
The goal of this observational study is to test the association between high levels of Galectin-3 and the occurrence of …
São Paulo, BrazilEst. completion Jan 27, 2026
PTA (Percutaneous Transluminal Angioplasty)Femoropopliteal Artery DiseaseLong Femoropopliteal Artery Disease
The purpose of this study is to evaluate the long-term safety and efficacy of GENOSS PCB in patients with long femoropop…
Suwon, South KoreaEst. completion Dec 31, 2028